Perbedaan Indosat Tbk. dan Organon Pharma Indonesia Tbk.: Indosat Tbk. diperdagangkan di Rp2.430 (kapitalisasi pasar 77,4 T, volume 24 jam 93,15 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Indosat Tbk. jauh lebih besar — sekitar 741,4× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| ISAT | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 77,4 T | 104,4 M |
Volume | 93,15 jt | — |
Lot | 931,49 rb | — |
Perputaran | 223,55 M | — |
Harga Rata-rata | 2.399,91 | — |
Nilai Transaksi | 223,55 M | — |
Harga Ekuilibrium Indikatif | 2.430 | — |
Volume Ekuilibrium Indikatif | 38,19 rb | — |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
Indonesian Satellite Corporation Tbk, PT (Persero), was established on November 10, 1967 within the framework of the Indonesian foreign Investment Law No. 1 of 1967. The company’s articles of association have been amended from time to time, most recently on Sept 4, 1997, concerning the changes in the articles of association to conform with Law No. 1 of 1995 on limited liability companies.
Selengkapnya di halaman ISAT →PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →